trial · primary record
Direct intravenous injection of ivlv-X1 lentiviral vector
SCID, X-Linked
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 10 |
| Primary completion | 2029-12-31 |
| Primary endpoint | Overall survival |
| Registry ID | NCT03217617 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:16.215Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03217617
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.